Lung Transplantation

• 

  Subject Areas on Research

  • A Conserved Distal Lung Regenerative Pathway in Acute Lung Injury. 
  • A Propensity-matched Survival Analysis: Do Simultaneous Liver-lung Transplant Recipients Need a Liver? 
  • A case of disseminated infection with Nocardia brasiliensis in a lung transplant recipient. 
  • A comparative analysis of bronchial stricture after lung transplantation in recipients with and without early acute rejection. 
  • A nonlinear relationship between visceral adipose tissue and frailty in adult lung transplant candidates. 
  • A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. 
  • A simplified technique for pulmonary artery aneurysm repair in a lung transplant recipient with right ventricular outflow tract obstruction. 
  • A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. 
  • ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine. 
  • Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. 
  • Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach. 
  • Active rehabilitation during extracorporeal membrane oxygenation as a bridge to lung transplantation. 
  • Acute allograft rejection: cellular and humoral processes. 
  • Acute cellular and antibody-mediated allograft rejection. 
  • Acute cellular rejection and humoral sensitization in lung transplant recipients. 
  • Acute kidney injury after ex vivo lung perfusion (EVLP). 
  • Acute kidney injury increases mortality after lung transplantation. 
  • Acute rejection and humoral sensitization in lung transplant recipients. 
  • Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. 
  • Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study. 
  • Advances in Human Lung Transplantation. 
  • Adverse outcomes associated with postoperative atrial arrhythmias after lung transplantation: A meta-analysis and systematic review of the literature. 
  • Aggressive pursuit and utilization of non-ideal donor lungs does not compromise post-lung transplant survival. 
  • Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. 
  • Alemtuzumab induction in lung transplantation: time to move on? 
  • Allocation of transplantable organs: do people want to punish patients for causing their illness? 
  • Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients. 
  • Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide. 
  • Aluminum-induced pneumoconiosis confirmed by analytical scanning electron microscopy: A case report and review of the literature. 
  • Ambulatory ECMO as a bridge to lung transplant in a previously well pediatric patient with ARDS. 
  • Ambulatory extracorporeal membrane oxygenation as a bridge to lung transplantation: walking while waiting. 
  • American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. 
  • American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. 
  • Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantation. 
  • An acute change in lung allocation score and survival after lung transplantation: a cohort study. 
  • An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. 
  • An unwelcome guest: Aspergillus colonization in lung transplantation and its association with bronchiolitis obliterans syndrome. 
  • Anastomotic infections in lung transplant recipients. 
  • Anesthesia for Lung Transplantation. 
  • Anesthetic management of the patient with extracorporeal membrane oxygenator support. 
  • Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis. 
  • Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work? 
  • Antibody desensitization therapy in highly sensitized lung transplant candidates. 
  • Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. 
  • Anticoagulation Strategies in the Perioperative Period for Lung Transplant. 
  • Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. 
  • Aprotinin's effect on blood product transfusion in off-pump bilateral lung transplantation. 
  • Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole. 
  • Assessing oropharyngeal dysphagia after lung transplantation: altered swallowing mechanisms and increased morbidity. 
  • Assessing the causal effect of organ transplantation on the distribution of residual lifetime. 
  • Assessment of different threshold preoperative glomerular filtration rates as markers of outcomes in lung transplantation. 
  • Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort. 
  • Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry. 
  • Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. 
  • Atrial fibrillation after pulmonary transplant. 
  • Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. 
  • Bacteremia in lung transplant recipients in the current era. 
  • Banff Lung Report: Current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR). 
  • Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies. 
  • Baseline 6-min walk distance predicts survival in lung transplant candidates. 
  • Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. 
  • Beyond the eyeball test: Measures of frailty in lung transplantation. 
  • Bilateral pneumonectomy with veno-arterial extracorporeal membrane oxygenation as a bridge to lung transplant. 
  • Bilateral sequential lung and simultaneous pancreas transplant: a new approach for the recipient with cystic fibrosis. 
  • Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation. 
  • Blood product transfusion and lung transplant outcomes: A systematic review. 
  • Body composition and mortality after adult lung transplantation in the United States. 
  • Bronchial anastomotic complications in lung transplant recipients: virtual bronchoscopy for noninvasive assessment. 
  • Bronchial epithelial injury in the context of alloimmunity promotes lymphocytic bronchiolitis through hyaluronan expression. 
  • Bronchiolitis obliterans syndrome in lung transplant recipients: correlation of computed tomography findings with bronchiolitis obliterans syndrome stage. 
  • Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. 
  • Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration. 
  • Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings. 
  • Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection. 
  • Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents. 
  • Cardiothoracic Transplant Anesthesia: Selected Highlights: Part I-Lung Transplantation. 
  • Cardiothoracic Transplant Recipient Mycoplasma hominis: An Uncommon Infection with Probable Donor Transmission. 
  • Case 260: Endobronchial Posttransplantation Lymphoproliferative Disease. 
  • Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury. 
  • Cellular immunology markers postransplantation predictive of long-term graft outcome. 
  • Center volume and primary graft dysfunction in patients undergoing lung transplantation in the United States - a cohort study. 
  • Changes in neurocognitive functioning following lung transplantation. 
  • Chest Fat Quantification via CT Based on Standardized Anatomy Space in Adult Lung Transplant Candidates. 
  • Chronic aspiration of gastric fluid accelerates pulmonary allograft dysfunction in a rat model of lung transplantation. 
  • Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. 
  • Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT. 
  • Circulating donor antigen and response to donor antigen as predictors of long-term lung and kidney transplant success. 
  • Citalopram and quality of life in lung transplant recipients. 
  • Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. 
  • Clinical outcome after coronary artery revascularization and lung transplantation. 
  • Clinical predictors and outcome implications of early readmission in lung transplant recipients. 
  • Clinical risk factors for primary graft dysfunction after lung transplantation. 
  • Clinical year in review I: quality improvement for pulmonary and critical care medicine, lung transplantation, rehabilitation for pulmonary and critically ill patients, and sleep medicine. 
  • Coagulopathy in α-galactosyl transferase knockout pulmonary xenotransplants. 
  • Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation. 
  • Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study. 
  • Combined lung-liver-pancreas transplantation in a recipient with cystic fibrosis. 
  • Commentary: Adding fuel to the fire for mechanical support during lung transplantation-More might be better. 
  • Commentary: Deep venous thrombosis in lung transplant recipients-tip of the iceberg that can potentially affect long-term outcome? 
  • Commentary: Failing grades. 
  • Commentary: Innovation…or disruption and the delayed acknowledgement of a new reality. 
  • Commentary: Repair or replace-Potts shunt versus lung transplantation for refractory pediatric pulmonary hypertension. 
  • Commentary: Rethinking the Role of Gastroesophageal Reflux in Lung Transplant Candidates. 
  • Commentary: The burning questions of reflux management in lung transplantation. 
  • Commentary: The jury is out-expanding eligibility for lung transplantation after hematopoietic stem cell transplantation. 
  • Community respiratory viral infection in adult lung transplant recipients. 
  • Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. 
  • Complement system in lung transplantation. 
  • Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: incidence, radiologic features, and clinical importance. 
  • Complications of lung transplantation: radiologic findings. 
  • Computer-assisted design of an implantable, intrathoracic artificial lung. 
  • Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. 
  • Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and International Society for Heart and Lung Transplantation: An executive summary. 
  • Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation. 
  • Constrictive Pericarditis After Lung Transplantation. 
  • Construct validity of the definition of primary graft dysfunction after lung transplantation. 
  • Contemporary trends in PGD incidence, outcomes, and therapies. 
  • Controlled non-heart-beating donors: a potential source of extrarenal organs. 
  • Coping and quality of life in patients awaiting lung transplantation. 
  • Coronary revascularization in lung transplant recipients with concomitant coronary artery disease. 
  • Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis. 
  • Critical care aspects of lung transplantation. 
  • Critical care perspective on immunotherapy in lung transplantation. 
  • Cromolyn ameliorates acute and chronic injury in a rat lung transplant model. 
  • Cumulative exposure to CD8+ granzyme Bhi T cells is associated with reduced lung function early after lung transplantation. 
  • Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant. 
  • Current challenges and opportunities in the management of antibody-mediated rejection in lung transplantation. 
  • Current concepts and controversies in lung transplantation. 
  • Cystic fibrosis: usefulness of thoracic CT in the examination of patients before lung transplantation. 
  • Cytokine gene polymorphisms are not associated with bronchiolitis obliterans syndrome or survival after lung transplant. 
  • Cytokine genotypes in kidney, heart, and lung recipients: consequences for acute and chronic rejection. 
  • Cytomegalovirus infection presenting as bronchial polyps in lung transplant recipients. 
  • Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. 
  • De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. 
  • Decreased Antibiotic Utilization After Sinus Surgery in Cystic Fibrosis Patients With Lung Transplantation. 
  • Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir. 
  • Delayed Alveolar Epithelialization: A Distinct Pathology in Diffuse Acute Lung Injury. 
  • Delayed right heart failure following lung transplantation. 
  • Delirium affects length of hospital stay after lung transplantation. 
  • Demystifying "bad luck": Seemingly unrelated risk factors for CLAD may be connected by a common pathway. 
  • Dendriform pulmonary ossification leading to bilateral lung transplant: a case report. 
  • Depletion of pulmonary intravascular macrophages prevents hyperacute pulmonary xenograft dysfunction. 
  • Depression, Immunosuppressant Levels, and Clinical Outcomes in Postlung Transplant Recipients. 
  • Depression, social support, and clinical outcomes following lung transplantation: a single-center cohort study. 
  • Depressive Symptoms, Exercise Capacity, and Clinical Outcomes After Lung Transplantation. 
  • Depressive symptoms and early mortality following lung transplantation: A pilot study. 
  • Depressive symptoms and mortality in lung transplant. 
  • Depressive symptoms, physical activity, and clinical events: The ADAPT prospective pilot study. 
  • Desensitization and management of allograft rejection. 
  • Design and evaluation of a new, low pressure loss, implantable artificial lung. 
  • Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients. 
  • Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate. 
  • Development and psychometric properties of the Pulmonary-specific Quality-of-Life Scale in lung transplant patients. 
  • Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. 
  • Diagnosis and outcome of early pleural space infection following lung transplantation. 
  • Diagnostic yield of bronchoscopies after isolated lung transplantation. 
  • Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection. 
  • Differential effects of donor-specific alloantibody. 
  • Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. 
  • Direct-from-blood RNA sequencing identifies the cause of post-bronchoscopy fever. 
  • Discussion. 
  • Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry. 
  • Disruption of iron homeostasis in the lungs of transplant patients. 
  • Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. 
  • Do donors matter? Short telomeres and survival after lung transplant. 
  • Does hyperexpansion of the native lung adversely affect outcome after single lung transplantation for emphysema? Preliminary findings. 
  • Donation after cardiac death: the University of Wisconsin experience. 
  • Donor-Derived Mycoplasma hominis and an Apparent Cluster of M. hominis Cases in Solid Organ Transplant Recipients. 
  • Dual Procurement of Lung and Heart Allografts Does Not Negatively Affect Lung Transplant Outcomes. 
  • Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation. 
  • Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. 
  • Early Immune Response to Acute Gastric Fluid Aspiration in a Rat Model of Lung Transplantation. 
  • Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. 
  • Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation. 
  • Economic Outcomes of Extracorporeal Membrane Oxygenation With and Without Ambulation as a Bridge to Lung Transplantation. 
  • Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction. 
  • Effect of an anti-C5a monoclonal antibody indicates a prominent role for anaphylatoxin in pulmonary xenograft dysfunction. 
  • Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. 
  • Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. 
  • Effects of a telephone-based psychosocial intervention for patients awaiting lung transplantation. 
  • Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. 
  • Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. 
  • Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. 
  • Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. 
  • Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. 
  • Emotional distress and quality of life in caregivers of patients awaiting lung transplant. 
  • Epidemiology of invasive mold infections in lung transplant recipients. 
  • Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation. 
  • Esophageal Dysmotility, Gastro-esophageal Reflux Disease, and Lung Transplantation: What Is the Evidence? 
  • Esophageal and Gastric Motility Changes Following Lung Transplantation. 
  • Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation. 
  • Evaluation of host cellular responses to Epstein-Barr virus (EBV) in adult lung transplant patients with EBV-associated diseases. 
  • Evidence for polyreactive xenoreactive antibodies in the repertoire of human anti-swine antibodies: the 'next' humoral barrier to xenotransplantation? 
  • Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population. 
  • Expanding donor availability in lung transplantation: A case report of 5000 miles traveled. 
  • Exposure of difficult left hilum in bilateral sequential lung transplantation. 
  • Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study. 
  • Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. 
  • Extracorporeal membrane oxygenation post lung transplantation. 
  • FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression. 
  • Factors associated with short- versus long-term survival after lung transplant. 
  • Failure to Rescue Contributes to Center-Level Differences in Mortality After Lung Transplantation. 
  • Failure to rescue in the era of the lung allocation score: The impact of center volume. 
  • Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literature. 
  • Frailty and aging-associated syndromes in lung transplant candidates and recipients. 
  • Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician. 
  • Frequency and CT findings of recurrent disease after lung transplantation. 
  • Functional status after lung transplantation in older adults in the post-allocation score era. 
  • Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. 
  • Gas exchange and exercise capacity affect neurocognitive performance in patients with lung disease. 
  • Gastroesophageal reflux and altered motility in lung transplant rejection. 
  • Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. 
  • Gastroesophageal reflux disease in lung transplant recipients. 
  • Gastroesophageal reflux disease-induced aspiration injury following lung transplantation. 
  • Gastroesophageal reflux symptoms are not sufficient to guide esophageal function testing in lung transplant candidates. 
  • Gene Expression Profiling of Bronchoalveolar Lavage Cells During Aspergillus Colonization of the Lung Allograft. 
  • Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction. 
  • Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality? 
  • Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. 
  • Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. 
  • Genomic characterization of recurrent mold infections in thoracic transplant recipients. 
  • Getting to transplantation. 
  • Giant cell interstitial pneumonia in patients without hard metal exposure: analysis of 3 cases and review of the literature. 
  • Glutathione depletion in epithelial lining fluid of lung allograft patients. 
  • Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation. 
  • High frequency of bronchogenic carcinoma after single-lung transplantation. 
  • High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control. 
  • Highlights from the clinical trials in organ transplantation (CTOT)-20 and CTOT-22 Consortium studies in lung transplant. 
  • Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction. 
  • Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. 
  • Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity. 
  • Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation. 
  • Hyperpolarized 3He-enhanced MR imaging of lung transplant recipients: preliminary results. 
  • Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation. 
  • IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control. 
  • ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements. 
  • ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements. 
  • ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements. 
  • Identifying host microRNAs in bronchoalveolar lavage samples from lung transplant recipients infected with Aspergillus. 
  • Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. 
  • Imaging in Lung Transplantation: So Near and Yet So Far. 
  • Immune cells in a mouse airway model of obliterative bronchiolitis. 
  • Immune mechanisms of lung allograft rejection. 
  • Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation. 
  • Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study. 
  • Impact of Donor Brain Death Duration on Outcomes After Lung Transplantation. 
  • Impact of Tacrolimus Trough Variability on Acute Rejection Following Lung Transplantation. 
  • Impact of donor and recipient hepatitis C status in lung transplantation. 
  • Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction. 
  • Impact of lung transplant operation on bronchiolitis obliterans syndrome in patients with chronic obstructive pulmonary disease. 
  • Impact of lung transplantation on recipient quality of life: a serial, prospective, multicenter analysis through the first posttransplant year. 
  • Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation. 
  • Impact of the lung allocation score on survival beyond 1 year. 
  • Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres. 
  • Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry. 
  • Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients. 
  • Implications of blood group on lung transplantation rates: A propensity-matched registry analysis. 
  • Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation. 
  • Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. 
  • Improved results treating lung allograft failure with venovenous extracorporeal membrane oxygenation. 
  • Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation. 
  • Improved survival in simultaneous lung-liver recipients and candidates in the modern era of lung allocation. 
  • In pursuit of new experimental models of obliterative bronchiolitis. 
  • In the face of chronic aspiration, prolonged ischemic time exacerbates obliterative bronchiolitis in rat pulmonary allografts. 
  • In vitro modeling of nonhypoxic cold ischemia-reperfusion simulating lung transplantation. 
  • In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study. 
  • Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry. 
  • Incidence of acute cellular rejection following granulocyte colony-stimulating factor administration in lung transplantation: A retrospective case-cohort analysis. 
  • Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation. 
  • Infections in patients with cystic fibrosis following lung transplantation. 
  • Infectious complications of lung transplantation. 
  • Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. 
  • Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. 
  • Inhaled Pulmonary Vasodilator Therapy in Adult Lung Transplant: A Randomized Clinical Trial. 
  • Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3. 
  • Innate immunity influences long-term outcomes after human lung transplant. 
  • International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation. 
  • International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. 
  • Interpreting positive cultures in asymptomatic lung transplant recipients. 
  • Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis. 
  • Iron accumulation in lung allografts after transplantation. 
  • Is Functional Independence Associated With Improved Long-Term Survival After Lung Transplantation? 
  • Is prevention the best treatment? CMV after lung transplantation. 
  • Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? 
  • It Is Not the Flicker but the Fire: Severity Matters in Viral infections After Lung Transplant. 
  • J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. 
  • JAK-STAT activation contributes to cytotoxic T cell-mediated basal cell death in human chronic lung allograft dysfunction. 
  • Kaposi sarcoma after bilateral lung transplantation. 
  • Laparoscopic Nissen fundoplication for treating reflux in lung transplant recipients. 
  • Laparoscopic antireflux surgery in the lung transplant population. 
  • Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis. 
  • Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. 
  • Like a phoenix: The rise of an extracorporeal membrane oxygenation program. 
  • Living-related lobar lung transplantation. 
  • Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial. 
  • Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry. 
  • Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft Dysfunction. 
  • Lung Donation After Death Resulting From a Stanford Type A Aortic Dissection. 
  • Lung Retransplantation. 
  • Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality. 
  • Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants. 
  • Lung Transplant Pulmonologists' Views of Specialty Palliative Care for Lung Transplant Recipients. 
  • Lung Transplantation After Ex Vivo Lung Perfusion Early Outcomes From a US National Registry. 
  • Lung Transplantation and the Era of the Sensitized Patient. 
  • Lung Transplantation: Controversies and Evolving Concepts. 
  • Lung allograft standardized histological analysis (LASHA) template: A research consensus proposal. 
  • Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome. 
  • Lung transplantation after ex vivo lung perfusion versus static cold storage: An institutional cost analysis. 
  • Lung transplantation after long-term mechanical ventilation : results and 1-year follow-up. 
  • Lung transplantation at Duke University Medical Center. 
  • Lung transplantation at Duke University Medical Center. 
  • Lung transplantation at Duke University. 
  • Lung transplantation delays gastric motility in patients without prior gastrointestinal surgery-A single-center experience of 412 consecutive patients. 
  • Lung transplantation during the COVID-19 pandemic: Safely navigating the new "normal". 
  • Lung transplantation exacerbates gastroesophageal reflux disease. 
  • Lung transplantation for Williams-Campbell syndrome. 
  • Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. 
  • Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease. 
  • Lung transplantation in advanced COPD: is it worth it? 
  • Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. 
  • Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience. 
  • Lung transplantation: advances in immunosuppression. 
  • Lung transplantation: evolving concepts and controversies. 
  • Lung-resident mesenchymal stromal cells. A new player in post-transplant bronchiolitis obliterans syndrome? 
  • Management of Lung Transplant Bronchial Stenosis With Mitomycin C. 
  • Medication Nonadherence After Lung Transplantation in Adult Recipients. 
  • Mitral Regurgitation After Orthotopic Lung Transplantation: Natural History and Impact on Outcomes. 
  • Multimedia Education Reduces Anxiety in Lung Transplant Patients. 
  • Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. 
  • Mycobacterium tuberculosis in lung transplant recipients. 
  • Mycoplasma hominis pneumonia complicating bilateral lung transplantation: case report and review of the literature. 
  • National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation. 
  • Neurobehavioral functioning and survival following lung transplantation. 
  • Neurocognitive changes after lung transplantation. 
  • Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. 
  • New developments in the diagnosis and treatment of infections in lung transplant recipients. 
  • Nocardia infection in lung transplant recipients. 
  • Non-anti-Gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. 
  • Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension. 
  • Noteworthy Literature Published in 2018 for Thoracic Organ Transplantation. 
  • Novel Magnetic Resonance Imaging for Assessment of Bronchial Stenosis in Lung Transplant Recipients. 
  • Novel Use of Mobile Ex-Vivo Lung Perfusion in Donation After Circulatory Death Lung Transplantation. 
  • Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. 
  • Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. 
  • Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients. 
  • Organ allocation around the world: insights from the ISHLT International Registry for Heart and Lung Transplantation. 
  • Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. 
  • Orthotopic Transplantation of Human Bioartificial Lung Grafts in a Porcine Model: A Feasibility Study. 
  • Osteoporosis in lung transplant candidates compared to matched healthy controls. 
  • Outcome of lung transplant patients admitted to the medical ICU. 
  • Outcome of lung transplantation in patients with mycetomas. 
  • Outcomes of primary total joint arthroplasty after lung transplantation. 
  • Parenteral administration of oral medications in lung transplant recipients: An underrecognized problem. 
  • Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients. 
  • Patient-Reported Chronic Pain Outcomes After Lung Transplantation. 
  • Patterns and predictors of pain following lung transplantation. 
  • Perioperative Management of Bleeding and Transfusion for Lung Transplantation. 
  • Peripheral blood allogeneic microchimerism in lung and cardiac allograft recipients. 
  • Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology. 
  • Perspectives on donor lung allocation from both sides of the Atlantic: The United States. 
  • Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction. 
  • Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. 
  • Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. 
  • Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. 
  • Plasmablastic myeloma/leukemia variant of monomorphic posttransplant lymphoproliferative disorder. 
  • Pleural effusions in lung transplant recipients: image-guided small-bore catheter drainage. 
  • Pneumatosis intestinalis after lung transplant. 
  • Pneumatosis intestinalis and pneumoperitoneum after bilateral lung transplantation in adults. 
  • Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation. 
  • Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis. 
  • Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. 
  • Portal hypertension and granulomatous liver disease in a lung transplant recipient due to disseminated atypical mycobacterial infection. 
  • Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients. 
  • Postoperative cognitive dysfunction and mortality following lung transplantation. 
  • Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. 
  • Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. 
  • Pre-transplant weight loss and clinical outcomes after lung transplantation. 
  • Predictors of Older Donor Lung Use: Are We Too Good at Saying No? 
  • Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. 
  • Predictors of nonuse of donation after circulatory death lung allografts. 
  • Preoperative mild-to-moderate coronary artery disease does not affect long-term outcomes of lung transplantation. 
  • Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. 
  • Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients. 
  • Prevention of acute lung injury in swine: depletion of pulmonary intravascular macrophages using liposomal clodronate. 
  • Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc group. 
  • Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients. 
  • Primary graft dysfunction and health-related quality of life after transplantation: The good, the bad, and the missing. 
  • Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study. 
  • Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction. 
  • Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation. 
  • Progression of idiopathic pulmonary fibrosis in native lungs after single lung transplantation. 
  • Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant. 
  • Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts. 
  • Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk. 
  • Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. 
  • Psychiatric disorder and quality of life in patients awaiting lung transplantation. 
  • Psychosocial Predictors of Mortality Following Lung Transplantation. 
  • Psychosocial issues in the assessment and management of patients undergoing lung transplantation. 
  • Pulmonary arterial impedance after single lung transplantation. 
  • Pulmonary dysfunction after lung transplantation: the dilemma of coexisting mitral regurgitation. 
  • Pulmonary embolization of microcrystalline cellulose in a lung transplant recipient. 
  • Pulmonary hypoplasia. 
  • Pulmonary rehabilitation in the surgical patient. Lung transplantation and lung volume reduction surgery. 
  • Pulmonary rehabilitation of the patient with nonobstructive lung disease. 
  • Putting the 2019 CLAD consensus definitions to the test: Two steps forward, one step back? 
  • Quality, quantity, or both? Life after lung transplantation. 
  • Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. 
  • Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation. 
  • Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. 
  • Radiologic issues in lung transplantation for end-stage pulmonary disease. 
  • Recurrence of diffuse panbronchiolitis after lung transplantation. 
  • Reduced Cerebral Perfusion Pressure during Lung Transplant Surgery Is Associated with Risk, Duration, and Severity of Postoperative Delirium. 
  • Reflux Surgery in Lung Transplantation: A Multicenter Retrospective Study. 
  • Reflux and allograft dysfunction: is there a connection? 
  • Reflux of bile acids: an innate problem of lung transplantation. 
  • Remote ex vivo lung perfusion at a centralized evaluation facility. 
  • Removal of Epithelialized Uncovered Metal Stent. A New Approach to An Old Problem. 
  • Repeatability of Computerized Tomography-Based Anthropomorphic Measurements of Frailty in Patients With Pulmonary Fibrosis Undergoing Lung Transplantation. 
  • Reperfusion edema after lung transplantation: effect of daclizumab. 
  • Reply to Marinelli and Rotstein. 
  • Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations. 
  • Respiratory failure early after lung transplantation: now that we know the extent of the problem, what are the solutions? 
  • Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. 
  • Response to "Does Sleep Play a Role in the Relationship Among Depression, Anxiety, and Mortality in Lung Transplanted Patients?". 
  • Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection. 
  • Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study. 
  • Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study. 
  • Risk factors for mortality in lung transplant recipients aged ≥65 years: A retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients. 
  • Risk factors for reperfusion injury after lung transplantation. 
  • Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease. 
  • Risk versus reward: total joint arthroplasty outcomes after various solid organ transplantations. 
  • Rituximab-associated progressive multifocal leukoencephalopathy after lung transplantation. 
  • Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation. 
  • Role of complement activation in obliterative bronchiolitis post-lung transplantation. 
  • Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies. 
  • Safety of Inhaled Amphotericin B Lipid Complex as Antifungal Prophylaxis in Lung Transplant Recipients. 
  • Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. 
  • Safety of hyperbaric oxygen therapy for management of central airway stenosis after lung transplant. 
  • Sarcoidosis. 
  • Secondary Pulmonary Hypertension; getting down to the nuts and BOLT. Author's reply to Ranganath et al. 
  • Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation. 
  • Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. 
  • Serial monitoring of exhaled nitric oxide in lung transplant recipients. 
  • Significance of and risk factors for the development of central airway stenosis after lung transplantation. 
  • Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. 
  • Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis. 
  • Single lung transplantation in patients with severe secondary pulmonary hypertension. 
  • Single-lung transplantation in the United States: what happens to the other lung? 
  • Sinusitis caused by the fungus Xylaria enteroleuca in a lung transplant recipient. 
  • Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. 
  • Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study. 
  • Smoking Relapse After Lung Transplantation: Is a Second Transplant Justified? 
  • Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study. 
  • Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation. 
  • Split-Bolus, Single-Acquisition, Dual-Phase Abdominopelvic CT Angiography for the Evaluation of Lung Transplant Candidates: Image Quality and Resource Utilization. 
  • Spontaneously Breathing Extracorporeal Membrane Oxygenation Support Provides the Optimal Bridge to Lung Transplantation. 
  • Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time. 
  • Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis. 
  • Subnormothermic ex vivo lung perfusion attenuates graft inflammation in a rat transplant model. 
  • Successful bilateral lung transplant outcomes in recipients 61 years of age and older. 
  • Successful bilateral lung transplantation for lymphangiomatosis. 
  • Successful extrarenal transplantation from non-heart-beating donors. 
  • Surgical considerations in lung transplantation: transplant operation and early postoperative management. 
  • Surgical correction of gastroesophageal reflux in lung transplant patients is associated with decreased effector CD8 cells in lung lavages: a case series. 
  • Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. 
  • Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation. 
  • Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. 
  • Survival after bronchiolitis obliterans syndrome. 
  • Survival after lung transplantation in recipients with alpha-1-antitrypsin deficiency compared to other forms of chronic obstructive pulmonary disease: a national cohort study. 
  • Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. 
  • Survival difference between high-risk and low-risk CFTR genotypes after lung transplant. 
  • Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. 
  • Swine lungs expressing human complement-regulatory proteins are protected against acute pulmonary dysfunction in a human plasma perfusion model. 
  • Symptomatic pulmonary allograft Kaposi's sarcoma in two lung transplant recipients. 
  • Syringe cap prevents leaks during one-lung ventilation. 
  • T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control. 
  • TRALI by proxy. 
  • Telephone-based coping skills training for patients awaiting lung transplantation. 
  • Telescoping bronchial anastomoses for unilateral or bilateral sequential lung transplantation: CT appearance. 
  • Temporal trends in lung transplant center volume and outcomes in the United States. 
  • Tests for 2 x K contingency tables with clustered ordered categorical data. 
  • Textbook Outcome: Definition and Analysis of a Novel Quality Measure in Lung Transplantation. 
  • Textbook outcome in lung transplantation: Planned venoarterial extracorporeal membrane oxygenation versus off-pump support for patients without pulmonary hypertension. 
  • Textbook surgical outcome in lung transplantation: Analysis of a US national registry. 
  • The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. 
  • The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: The use of mechanical circulatory support in lung transplantation. 
  • The Association of Increased FFP:RBC Transfusion Ratio to Primary Graft Dysfunction in Bleeding Lung Transplantation Patients. 
  • The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation. 
  • The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome. 
  • The Year in Cardiothoracic Transplant Anesthesia: Selected Highlights From 2020 Part I - Lung Transplantation. 
  • The association of donor age and survival is independent of ischemic time following deceased donor lung transplantation. 
  • The effect of prior pneumonectomy or lobectomy on subsequent lung transplantation. 
  • The effects of brain death on cardiopulmonary hemodynamics and pulmonary blood flow characteristics. 
  • The efficiency of pulmonary blood transport following single lung transplantation. 
  • The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. 
  • The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. 
  • The role of bronchoscopy in the management of lung transplant recipients. 
  • The role of hyaluronan degradation products as innate alloimmune agonists. 
  • The role of innate immunity in acute allograft rejection after lung transplantation. 
  • The role of soluble and insoluble gastric fluid components in the pathogenesis of obliterative bronchiolitis in rat lung allografts. 
  • The role of the porcine von Willebrand factor: baboon platelet interactions in pulmonary xenotransplantation. 
  • The trade-off of using positive-smoking donor lungs. 
  • The use of TP10, soluble complement receptor 1, in cardiopulmonary bypass. 
  • The use of genome sequencing to investigate an outbreak of hospital-acquired mucormycosis in transplant patients. 
  • The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates. 
  • The utility of preoperative six-minute-walk distance in lung transplantation. 
  • The wait for the waitlist: The next challenge in the lung allocation system. 
  • Therapies for refractory hypoxemia in acute respiratory distress syndrome. 
  • Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition Study. 
  • Thoracic organ transplantation at Papworth Hospital. 
  • Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry. 
  • Titrating Oxygen Requirements During Exercise: Evaluation of a Standardized Single Walk Test Protocol. 
  • Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor. 
  • Toll-like receptors and allograft rejection. 
  • Toll-like receptors, innate immunity and lung transplantation. 
  • Total pulmonary artery occlusion immediately after lung transplantation: successful revascularization with intravascular stents. 
  • Total respiratory support from swine lungs in primate recipients. 
  • Transplant size mismatch in restrictive lung disease. 
  • Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases. 
  • Treatment of refractory acute rejection in a lung transplant recipient with campath 1H. 
  • Two Cases of Late Shone Syndrome With Pulmonary Hypertension: Heart-Lung Transplant or Valve Surgery? 
  • Unethical studies on transplantation in cardiothoracic surgery journals. 
  • Update in lung transplantation 2013. 
  • Upper lobe fibrosis: a novel manifestation of chronic allograft dysfunction in lung transplantation. 
  • Use of lung allografts from brain-dead donors after cardiopulmonary arrest and resuscitation. 
  • Usefulness of gene expression profiling of bronchoalveolar lavage cells in acute lung allograft rejection. 
  • Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. 
  • Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients. 
  • Variability in donor organ offer acceptance and lung transplantation survival. 
  • Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. 
  • What Is the Optimal Transplant for Older Patients With Idiopathic Pulmonary Fibrosis? 
  • When Therapy Is Confounded With Approach: Retrospective Studies of Transfusion-Related Outcomes After Lung Transplantation. 
  • Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1. 
• 

  Keywords of People

  • Ali, Hakim Azfar, Associate Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Tsalik, Ephraim, Adjunct Associate Professor in the Department of Medicine, Medicine, Infectious Diseases
  • Turner, David Ashley, Consulting Professor in the Department of Pediatrics, Pediatrics, Critical Care Medicine
  • Weber, Jeremy, Biostatistician III, Biostatistics & Bioinformatics